Henghai Kaiwu, relying on the Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences and the National Key Laboratory of Low-Carbon Synthetic Engineering Biology, is a vibrant and innovative biomanufacturing startup. The company conducts research and production of various products including food supplements, health supplements, and chemical new materials, as well as related enzyme preparations, based on its original in-vitro bioconversion (ivBT) platform. It has gathered a professional team with background from R&D, finance, and intellectual property, and possesses full-process technical R&D, engineering, and production manufacturing experience from 0 to 1, 1 to 10, and 10 to 100.